Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2and serotonin 5-HT2Areceptor occupancy as measured by positron emission tomography (PET)
Yann Hodé, Amine Benyamina, Christophe Arbus, Matthias ReimoldVolume:
217
Language:
english
Pages:
7
DOI:
10.1007/s00213-011-2289-1
Date:
October, 2011
File:
PDF, 251 KB
english, 2011